SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001571049-15-006630
Filing Date
2015-08-12
Accepted
2015-08-12 14:40:52
Documents
9
Period of Report
2015-08-12
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 2.03: Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K t1501863_8k.htm 8-K 27826
2 EXHIBIT 4.1 t1501863_ex4-1.htm EX-4.1 648823
3 EXHIBIT 4.2 t1501863_ex4-2.htm EX-4.2 39335
4 EXHIBIT 4.3 t1501863_ex4-3.htm EX-4.3 39896
5 EXHIBIT 4.4 t1501863_ex4-4.htm EX-4.4 39734
6 EXHIBIT 4.5 t1501863_ex4-5.htm EX-4.5 39256
7 EXHIBIT 4.6 t1501863_ex4-6.htm EX-4.6 39927
8 EXHIBIT 5.1 t1501863_ex5-1.htm EX-5.1 10066
9 GRAPHIC logoex5-1.jpg GRAPHIC 4016
  Complete submission text file 0001571049-15-006630.txt   891735
Mailing Address 86 MORRIS AVENUE SUMMIT NJ 07901
Business Address 86 MORRIS AVENUE SUMMIT NJ 07901 (908)673-9000
CELGENE CORP /DE/ (Filer) CIK: 0000816284 (see all company filings)

IRS No.: 222711928 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-34912 | Film No.: 151046629
SIC: 2834 Pharmaceutical Preparations